Good Morning, Admin User! 👋
📚 Currently Reading
View All →No items currently reading
Start reading something from your library!
💡 Recent Key Learnings
View All →Telehealth + Pharmacy = New Power Players
Old Model: Doctor → Prescription → Pharmacy. New Model: App → AI Consultation → Direct-to-Consumer. Traditional pharmacies are being...
Compounding Pharmacies = Major Disruption
Brand-name drugs are expensive. Compounding pharmacies make copies at fraction of cost in regulatory gray zone. Every blockbuster drug will have...
The Fast Follower Pharma Model
Wait for FDA approval → Launch copycat → No R&D costs. This means less incentive for original drug development. Big Pharma may shift to licensing...
Regulation Will Be the Battleground
Two scenarios: Lax regulation = telehealth boom, more compounding, innovation slows, patient safety risks. Strict enforcement = traditional pharma...
Consumer Behavior is Changing
Patients want: convenience (home delivery), cash-pay to skip insurance, trust influencers as much as doctors, demand pricing transparency. Future...